Metronomia News

What’s up at METRONOMIA? Check out our news archive and read about our latest plans, events, milestones or key people.

05.07.2011: Metronomia Social Day

On the 5th of July, Metronomia spent a day working in an asylum-seekers' hostel in Munich.

Read more …

Meet us at the European Clinical Data Forum!

Metronomia is sponsoring the "European Clinical Data Forum", 24 - 25 May 2011 in Munich, Germany.This event bundles two conferences: "eClinical Trials" and "Clinical Data Management", both representing Metronomia’s core business. We are looking forward to welcome you at our booth!

Read more about this event: http://www.arena-international.com

Read more …

Study with innovative stem cell therapy in PAOD initiated in March 2001

Metronomia is providing monitoring, data management and statistical services for a randomized phase II study with innovative stem cell therapy in patients suffering from peripheral arterial occlusive disease. 

Read more …

Contracts with several new bio-pharmaceutical customers signed

During the last three months contracts with three new bio-pharmaceutical and biotech customers were signed. These customers develop therapies mainly in oncology and dermatology (amongst other indications).

Read more …

Statistical and programming services for four transplantation studies awarded to Metronomia

This month significant repeat business was generated: statistical and programming services for four international clinical trials was awarded to Metronomia by one of our long term customers, a global pharmaceutical company.

Read more …

Clinical Trials in Oncology

Metronomia sponsors the ViB Conference "Clinical Trials in Oncology" 2010 in Munich

Read more …

20 years of Metronomia

Metronomia was founded on September 12, 1990 and celebrates its 20st anniversary today .

Read more …

Contracts signed for EDC studies in oncology

Metronomia today announced the contract signing for two EDC trials in oncology with a leading German biotech company.

Read more …

Multinational, non-intervenational, ten-year EDC study awarded

Metronomia today announced the contract signing for a multinational, non-intervenational study, ten-year, 300-site, 1,500 patient EDC study with a global pharmaceutical company.

Read more …

Metronomia selected as preferred provider

Metronomia today announced the signing of a Master Services Agreement with one of the major global biotech companies.

Read more …